Ankylosing spondylitis trials in Netherlands
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
- Where
- Amsterdam, Heerlen, Rotterdam
- Age
- 18 years to 80 years
- People
- 315 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07133633 · EU 2025-521059-21-00 - Phase 1Taking peopleEAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1)
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 86 worldwide
- Run by
- Grey Wolf Therapeutics Limited
See details and how to join2025-521315-39-00 - Phase 1/2Taking peopleEAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
- Where
- Amsterdam, Leiden
- Age
- 18 years to 65 years
- People
- 140 worldwide
- Run by
- Grey Wolf Therapeutics
See details and how to joinNCT07047703 - Phase 4Not yet taking people in NetherlandsImpact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
- Where
- Nijmegen
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- CARE ARTHRITIS LTD.
See details and how to joinNCT07018206 · EU 2025-522118-21-00 - Phase 4Taking peopleREDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
- Where
- Amsterdam, Enschede, Harderwijk, Maastricht, Nijmegen, Rotterdam, Tilburg, Ubbergen, Uden, Zwolle
- Age
- 16 years and over
- People
- 200
- Run by
- Sint Maartenskliniek
See details and how to joinNCT07160231 · EU 2025-520757-36-00